The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
LX211, calcineurin inhibitor and antiinflammatory drug, was granted Fast Track designation by the FDA. This move could expedite its approval for the management of non-infectious posterior, intermediate and panuveitis. In a field where there are few approved treatment modalities, this could be very big...
This brief article describes the comments of the Advanced Medical Optics (AMO) President and CEO which deflect the blame of the recent contact lens infection on the consumer on poor contact lens hygiene. Although the comments of the AMO brass may be indeed true, there is not a single entity to...
Boxer Sugar Ray Leonard had a complex retinal detachment, Orlando Brown of football was nearly blinded by a referee's thrown flag. Soft contact lens wear is barely compatible with sweaty, dusty contact sports. Some great basketball players wore (& wear) goggles. Asking boxers to wear...
Biodem (ASX:BDM) is conducting a a Phase I/II trail involving a 10 day course of subcutaneous injection of a peptide in the treatment of diabetic macular edema. The results of this trial which is being conducted abroad in Russia will be available in November 2007. Although promising...
LX211, calcineurin inhibitor and antiinflammatory drug, was granted Fast Track designation by the FDA. This move could expedite its approval for the management of non-infectious posterior, intermediate and panuveitis. In a field where there are few approved treatment modalities, this could...
Rather than getting gobbled up by one of the big three players in Ophthalmology (B & L, Alcon and AMO), eyeonics is looking to go it alone into the public arena. The crystalens remains the only approved accommodative intraocular lens, but faces strong competition from the multifocals. ...
The new Medicare regulations are not based in science as there is no proven clear cut medical way to eliminate the incidence of these "so-called" medical errors. It would be a dream to believe that some intervention today can eliminate the occurrence of infections in hospitals or patient falls. ...
Tears of the retinal pigment epithelium (RPE) may develop during the course of anti-VEGF therapy for age-related macular degeneration (AMD) related pigment epithelial detachment (PED), according to a study published in the June issue of Retina. A total of 33 cases of RPE tear after treatment with...
This glaucoma drug efficacy crossover study shows that bimatoprost (Lumigan) from AGN lowers intraocular pressure better than latanoprost (Xalatan) from PFE in a special subset of glaucoma patients (exfoliative glaucoma). The difference is only 1 mm Hg which may be statistically significant will...
Bayer and Regeneron are moving forward with their Phase 3 Trial called the VIEW involving VEGF Trap for the treatment for choroidal neovascularization in Age Related Macular Degeneration. The implications are large for a billion dollar market that is currently dominated by Lucentis (DNA).